WES | ||
---|---|---|
OUTLOOK RATING 1..100 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 3 | |
SMR RATING 1..100 | 24 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 30 | |
SEASONALITY SCORE 1..100 | 41 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IAF | WES | |
---|---|---|
RSI ODDS (%) | 2 days ago84% | N/A |
Stochastic ODDS (%) | 2 days ago88% | 2 days ago77% |
Momentum ODDS (%) | 2 days ago84% | 2 days ago49% |
MACD ODDS (%) | 2 days ago85% | 2 days ago45% |
TrendWeek ODDS (%) | 2 days ago83% | 2 days ago69% |
TrendMonth ODDS (%) | 2 days ago80% | 2 days ago44% |
Advances ODDS (%) | 3 days ago83% | 11 days ago68% |
Declines ODDS (%) | 5 days ago87% | 9 days ago50% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago67% |
Aroon ODDS (%) | 2 days ago84% | 2 days ago64% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MRSK | 35.69 | 0.07 | +0.20% |
Toews Agility Managed Risk ETF | |||
EVLN | 49.51 | 0.02 | +0.04% |
Eaton Vance Floating-Rate ETF | |||
PYT | 23.38 | N/A | N/A |
Merrill Lynch Depositor PPLUS Floating Rate Call TR Cert Ser GSC-2(Goldman Sachs) | |||
IBRN | 28.84 | N/A | N/A |
iShares Neuroscience and Healthcare ETF | |||
VLT | 11.01 | -0.17 | -1.53% |
Invesco High Income Trust II |
A.I.dvisor tells us that IAF and CSL have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IAF and CSL's prices will move in lockstep.